This population-based study explored the relationship between insulin analogues, chronic viral hepatitis, and HCC incidence among patients with newly-diagnosed type 2 diabetes who had been prescribed at least one kind of antidiabetic agent. This evidence concerns the gene INS and type 2 diabetes mellitus.